EU seeks new Covid-19 vaccine deal with Moderna, AstraZeneca flags doses made outside EU - sources
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Sunday
August 14, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
SUNDAY, AUGUST 14, 2022
EU seeks new Covid-19 vaccine deal with Moderna, AstraZeneca flags doses made outside EU - sources

Coronavirus chronicle

Reuters
15 February, 2021, 09:50 pm
Last modified: 15 February, 2021, 09:51 pm

Related News

  • Zelensky reiterates his demand, asks EU to impose travel ban on Russia
  • Bank agrees to process Russian oil transit payment to central Europe
  • The great European energy crisis is now coming for your food
  • Problems remain with Kaliningrad transit despite EU deal, Russia says
  • EU likely to be inflexible to all GSP+ standards: German ambassador

EU seeks new Covid-19 vaccine deal with Moderna, AstraZeneca flags doses made outside EU - sources

Under the deal being negotiated, the EU would secure 150 million additional doses from Moderna, on top of 160 million that have already been booked and have started being rolled out last month

Reuters
15 February, 2021, 09:50 pm
Last modified: 15 February, 2021, 09:51 pm
FILE PHOTO: An employee shows the Moderna coronavirus disease (Covid-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, US, December 21, 2020. REUTERS/Eduardo Munoz
FILE PHOTO: An employee shows the Moderna coronavirus disease (Covid-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, US, December 21, 2020. REUTERS/Eduardo Munoz

The EU is holding talks with Moderna on buying more Covid-19 vaccine and AstraZeneca, with which talks have stalled, has suggested delivering doses of its own vaccine made outside Europe to make up for supply cuts, two EU sources said.

The European Union has set a target of vaccinating 70% of its adult population by the end of the summer, but has struggled to secure the doses promised by pharmaceutical companies.

It is now trying to expand its reserve of vaccines, which already amount to nearly 2.3 billion doses from six drugmakers for its population of about 450 million.

The EU is negotiating a new supply deal with Moderna that could nearly double the volume of vaccine doses from the US biotech firm, two senior EU officials involved in the talks told Reuters.

They asked for anonymity as the talks are confidential.

Under the deal being negotiated, the EU would secure 150 million additional doses from Moderna, on top of 160 million that have already been booked and have started being rolled out last month.

One of the two officials said some of the doses under the new deal could be delivered by June.

The second was more cautious, pointing to difficulties Moderna has faced delivering just 10 million doses to the EU in the first quarter of 2021.

The volume of shots available could, however, be boosted if the number of doses that can be extracted from each Moderna vial is increased.

Moderna declined comment on the talks with the EU. But it said it was holding discussions with regulatory authorities in different countries on the possibility of increasing the number of doses in vials to 15 from 10.

The Commission did not immediately respond to a request for comment.

The EU is also close to finalising talks with Novavax for 200 million doses, one of the officials said, confirming a Reuters report from last week.

"BUILT ON SAND"

On Friday, officials in Brussels and executives from AstraZeneca discussed the cut in deliveries announced by the Anglo-Swedish drugmaker last month, when it told the EU it had reduced its supply targets for the bloc because of a production problem.

That would have cut deliveries to 31 million doses through March instead of the at least 80 million initially agreed.

Under pressure, AstraZeneca, which developed its vaccine with Oxford University, later offered to lift supplies to 40 million for the first quarter.

The EU and AstraZeneca are now holding weekly meetings to find ways to boost production quickly, the two sources said.

AstraZeneca executives told EU officials on Friday that to accelerate supplies to the bloc, it could provide it with some doses manufactured outside Europe, the two sources said. One said the Serum Institute of India (SII) could be a supplier.

The British drugs regulator is also auditing manufacturing processes at the SII plant, a move that could pave the way for AstraZeneca's vaccine to be shipped from there to Britain and other countries, two sources said.

SII is the main provider of vaccines to poorer countries under a scheme co-led by the World Health Organization. It is unclear whether these supplies could be affected by possible deliveries to wealthier countries.

AstraZeneca also mentioned a US manufacturing facility as a possible supplier for the EU, but did not indicate volumes or timing of deliveries, one of the sources said.

AstraZeneca and the SII were not immediately available to comment.

Both EU sources said the company's new offers lacked clarity. One source said it was still not clear whether AstraZeneca could deliver the 40 million doses pledged for the first three months of 2021, and there were only vague commitments for the second quarter.

"It's all built on sand," the official said.

EU officials have said the US vaccine factory AstraZeneca has mentioned is in Baltimore, but have given no more details.

Under deals announced last year, Catalent's Maryland facility will make the drug substance used in AstraZeneca's vaccine and Emergent BioSolutions Inc is making the shot at its Baltimore facility.

Deliveries from factories outside the EU would need to be authorised by the EU drug regulator, EU officials said.

The EU has said two factories producing AstraZeneca's vaccine in Britain should supply the EU under its contract with the company. AstraZeneca has said the British government prevented exports of the vaccine citing its own supply contract.

The British government has declined to say whether its contract with AstraZeneca gives priority to British supplies. 

Top News

EU / Moderna Covid-19 Vaccine / AstraZeneca Covid-19 Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Excess liquidity Tk2 lakh cr again but banks have little in hand
    Excess liquidity Tk2 lakh cr again but banks have little in hand
  • Photo: Collected
    Extract more local gas, explore solar power: Experts
  • Rising egg prices hit low-income people’s protein intake
    Rising egg prices hit low-income people’s protein intake

MOST VIEWED

  • North Korea's leader Kim Jong Un greets health workers and scientists struggling with the coronavirus disease (Covid-19) pandemic during a photo session in Pyongyang, North Korea, in this undated photo released on August 10, 2022 by North Korea's Korean Central News Agency (KCNA). KCNA via REUTERS
    North Korea lifts mask mandate, distancing rules after declaring Covid victory
  • A motorist passes by a mural of frontline workers against coronavirus at RK Puram in New Delhi on July 25. Delhi’s Covid-19 recoveries have outstripped new cases on almost all days this month barring a few exceptions, after ramped-up containment and testing efforts over the past month or so. (Sanchit Khanna / HT Photo)
    Delhi to enforce mask mandate again after spurt in Covid cases
  • A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell
    US CDC no longer recommends students quarantine for Covid-19 exposure
  • In this file photo taken on March 2, 2019, Kim Yo Jong, sister of North Korea's leader Kim Jong Un, attends a wreath-laying ceremony at Ho Chi Minh Mausoleum in Hanoi. Photo: Hindustan Times
    Kim Jong Un's sister warns Seoul of 'retaliation' over Covid
  • North Korean leader Kim Jong Un speaks at a politburo meeting of the Worker's Party on the country's coronavirus disease (COVID-19) outbreak response in this undated photo released by North Korea's Korean Central News Agency (KCNA) on May 21, 2022. KCNA via REUTERS
    North Korea declares victory over Covid, suggests leader Kim had it
  • Workers wearing protective suits arrive to a building under lockdown for compulsory testing, following the coronavirus disease (COVID-19) outbreak in Hong Kong, China January 7, 2022. Photo :Reuters
    Hong Kong cuts Covid quarantine stay for incoming travellers

Related News

  • Zelensky reiterates his demand, asks EU to impose travel ban on Russia
  • Bank agrees to process Russian oil transit payment to central Europe
  • The great European energy crisis is now coming for your food
  • Problems remain with Kaliningrad transit despite EU deal, Russia says
  • EU likely to be inflexible to all GSP+ standards: German ambassador

Features

Toes and talons of Shikra. Photo; Enam Ul Haque

Shikra: A leopard with wings!

13h | Panorama
Photo: Noor-A-Alam

Around the world in 10 days: A chance to taste global cuisines

12h | Food
Lobbyists float ludicrous arguments to prevent tobacco control act amendment

Lobbyists float ludicrous arguments to prevent tobacco control act amendment

15h | Panorama
Will US-China tensions boil over?

Will US-China tensions boil over?

13h | Panorama

More Videos from TBS

Eggs are selling at record prices

Eggs are selling at record prices

3h | Videos
Dollar price increase affecting Karnaphuli tunnel construction

Dollar price increase affecting Karnaphuli tunnel construction

3h | Videos
Climate crisis a blessing in disguise to them

Climate crisis a blessing in disguise to them

4h | Videos
Growing rice crisis shows how important food self-sufficiency is for Bangladesh

Growing rice crisis shows how important food self-sufficiency is for Bangladesh

6h | Videos

Most Read

1
Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 
Banking

Dollar crisis: BB orders removal of 6 banks’ treasury chiefs 

2
Photo: Collected
Transport

Will Tokyo’s traffic model solve Dhaka’s gridlocks?

3
Diesel price hiked by Tk34 per litre, Octane by Tk46
Energy

Diesel price hiked by Tk34 per litre, Octane by Tk46

4
Representational Image. Photo: Collected
Bangladesh

Air passengers should plan extra commute time to airport: DMP

5
Arrest warrant against Habib Group chairman, 4 others 
Crime

Arrest warrant against Habib Group chairman, 4 others 

6
File Photo: State Minister for Power, Energy and Mineral Resources Nasrul Hamid
Energy

All factories to remain closed once a week under rationing system

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]